Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Nature Communications
|
August 17, 2024
α-Synuclein oligomers form by secondary nucleation
Catherine K Xu, Georg Meisl, Ewa A Andrzejewska, et al.
Nature Structural & Molecular Biology
|
September 29, 2020
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
Sara Linse, Tom Scheidt, Katja Bernfur, et al.
Frontiers in Immunology
|
January 23, 2024
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy
Ashley Priddey, Michael Xin Hua Chen-Xu, Daniel James Cooper, et al.
Chemical Science
|
May 17, 2024
Molecular mechanism of α-synuclein aggregation on lipid membranes revealed
Alexander J Dear, Xiangyu Teng, Sarah R Ball, et al.
Nature Chemical Biology
|
March 20, 2024
Design of amyloidogenic peptide traps
Danny D Sahtoe, Ewa A Andrzejewska, Hannah L Han, et al.
Iscience
|
July 25, 2022
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D Brugger, et al.
Nature Communications
|
February 18, 2026
Structural defects in amyloid-β fibrils drive secondary nucleation
Jing Hu, Tom Scheidt, Dev Thacker, et al.
Life Science Alliance
|
December 1, 2021
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
Matthias M Schneider, Marc Emmenegger, Catherine K Xu, et al.
Neurology
|
February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutations
Karl Frontzek, Manfredi Carta, Marco Losa, et al.
ACS Chemical Neuroscience
|
December 21, 2022
Perphenazine-Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid
Sarah R Ball, Julius S P Adamson, Michael A Sullivan, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Nature Communications
|
August 17, 2024
α-Synuclein oligomers form by secondary nucleation
Catherine K Xu, Georg Meisl, Ewa A Andrzejewska, et al.
Nature Structural & Molecular Biology
|
September 29, 2020
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
Sara Linse, Tom Scheidt, Katja Bernfur, et al.
Frontiers in Immunology
|
January 23, 2024
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy
Ashley Priddey, Michael Xin Hua Chen-Xu, Daniel James Cooper, et al.
Chemical Science
|
May 17, 2024
Molecular mechanism of α-synuclein aggregation on lipid membranes revealed
Alexander J Dear, Xiangyu Teng, Sarah R Ball, et al.
Nature Chemical Biology
|
March 20, 2024
Design of amyloidogenic peptide traps
Danny D Sahtoe, Ewa A Andrzejewska, Hannah L Han, et al.
Iscience
|
July 25, 2022
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D Brugger, et al.
Nature Communications
|
February 18, 2026
Structural defects in amyloid-β fibrils drive secondary nucleation
Jing Hu, Tom Scheidt, Dev Thacker, et al.
Life Science Alliance
|
December 1, 2021
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
Matthias M Schneider, Marc Emmenegger, Catherine K Xu, et al.
Neurology
|
February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutations
Karl Frontzek, Manfredi Carta, Marco Losa, et al.
ACS Chemical Neuroscience
|
December 21, 2022
Perphenazine-Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid
Sarah R Ball, Julius S P Adamson, Michael A Sullivan, et al.
Page
of 13